a year ago

PulmoBioMed Raises £1.4 Million for Lung Testing Device

  • PulmoBioMed, a spinout from Northumbria University, has secured £1.4 million in funding to commercialize its lung testing technology for asthma diagnosis

  • The company has developed a non-invasive mouthpiece to collect fluid samples from the lungs, which is claimed to be 40 times cheaper than endoscopy

  • The funding came from the North East Venture Fund, Mercia Ventures, SFC Capital, private investors, and Northumbria University

  • PulmoBioMed plans to use the funds to target the US market and develop a cost-effective manufacturing process.

      • ProblemHealthcare

      "Current methods for diagnosing asthma are expensive and invasive, requiring endoscopy which involves a long tube with a small camera being passed down the throat and into the lung."

      Solution

      "PulmoBioMed has developed a non-invasive mouthpiece to collect fluid samples from the lungs to detect conditions like asthma. The handheld device, called PBM-HALE, separates aerosol droplets from the mouth from those originating from the deep lung. Samples are then stored in a separate coolant chamber developed by the spinout."

      Covered on